Analysis confirms benefit of nivolumab combo in teens with advanced Hodgkin lymphoma
Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the immunotherapy nivolumab (Opdivo) instead of the immunotherapy brentuximab vedotin (brand name Adcetris) along ...
1 minute ago
0
0









